Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization ...

Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric disease and orphan-designated indication, has reached approximately 95% enrollment and is expected to comp ...

A late-stage study found Cobenfy wasn’t better than a placebo as an add-on to atypical antipsychotics. Some analysts view the failure as a “significant hit” to the drug’s commercial outlook.

This third article in a seven part series presents the Core GRADE (Grading of Recommendations Assessment, Development and ...

ImmunityBio's sBLA for Anktiva was unexpectedly rejected by the FDA, contradicting prior positive feedback and approval for a ...

Federal regulators are asking Novavax NVAX-10.29%decrease; red down pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval ...

BOSTON, April 25, 2025--(BUSINESS WIRE)--Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines through its powerful ...

The dashboard provides real-time analytics on subject compliance, engagement, site performance, and visit adherence. Credit: © Clinical ink. All rights reserved ...

Spanning four continents and enrolling hundreds of people, a new clinical trial will test the effectiveness of two anti-inflammatory medicines as potential treatments for long COVID, scientists ...

Maca root could have benefits for people with erectile dysfunction (ED). A 2023 randomized, double-blind trial found that consuming gelatinized maca root helped reduce ED in people with late onset ...

The Department of the Air Force’s process for determining if airmen and Space Force guardians should receive medical waivers for shaving is about as indecipherable as the infamous flow chart ...